Sandra Horning speaks at an Endpoints News event during the #JPM19 healthcare conference (Jeff Rumans for Endpoints News)

September 6, 2019 06:41 AM EDT

Pharma

Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie

Natalie Grover

Reporter

Roche is stacking up approvals for its flagship checkpoint inhibitor in the lucrative field of lung cancer. On Friday, the Swiss drugmaker revealed that the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie

Natalie Grover

Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Roche boosts can­cer ap­provals in Eu­rope, push­ing for a big­ger slice of the I/O pie

Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie